DISCLOSEABLE AND CONNECTED TRANSACTION DISPOSAL OF 35% EQUITY INTEREST IN CELLPRO BIOTECH
Download
B
A
S
E
C
A
R
E
Announcements and Circulars
Basecare (2170.HK) will be listed on the main board of HKEX on 8 February 2021. The total offering size assuming over-allotment option not exercised and fully exercised were US$235mm and US$271mm, respectively.
-
-
-
-
DISCLOSEABLE TRANSACTION - ENTERING INTO THE GENERAL CONSTRUCTION CONTRACTS FOR THE CONSTRUCTION OF OUR HEADQUARTERS, R&D CENTER AND PLANTSDownload -
-
-
-
-
-
-
-
Form of Proxy for use at the 2021 Annual General Meeting to be held on Wednesday, June 8, 2022Download -
(1) 2021 REPORT OF THE BOARD OF DIRECTORS (2) 2021 REPORT OF THE BOARD OF SUPERVISORS (3) 2021 ANNUAL REPORT AND ITS ABSTRACT (4) 2021 FINANCIAL ACCOUNTS REPORT (5) 2022 FINANCIAL BUDGET (6) 2021 PROFIT DISTRIBUTION PLAN (7) RE-APPOINTMENT OF AUDITORS (8)Download -
-
-
-
-
-
PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR; PROPOSED CHANGE IN USE OF PROCEEDS; PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION AND NOTICE OF 2022 FIRST EXTRAORDINARY GENERAL MEETINGDownload -
Form of Proxy for use at the 2022 First Extraordinary General Meeting to be held on Saturday, April 30, 2022Download -
-
PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION RESIGNATION OF EXECUTIVE DIRECTOR PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR AND PROPOSED CHANGE IN USE OF PROCEEDSDownload -
-
INSIDE INFORMATION ANNOUNCEMENT THE H SHARE FULL CIRCULATION LISTING APPROVAL GRANTED BY THE STOCK EXCHANGEDownload -
INSIDE INFORMATION ANNOUNCEMENT - APPROVAL BY THE CSRC OF THE APPLICATION IN RESPECT OF H SHARE FULL CIRCULATION PROGRAMME OF THE COMPANYDownload -
-
-
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ACQUISITION OF 51% EQUITY INTEREST IN CELLPRO BIOTECHDownload -
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; PROPOSED CHANGE IN USE OF PROCEEDS AND NOTICE OF 2021 SECOND EXTRAORDINARY GENERAL MEETINGDownload -
-
-
-
Form of Proxy for use at the 2021 Second Extraordinary General Meeting to be held on Saturday, December 18, 2021Download -
-
DISCLOSEABLE TRANSACTION - ACQUISITION OF 51% EQUITY INTEREST IN CELLPRO BIOTECH AND CHANGE IN USE OF PROCEEDSDownload -
-
-
CHANGE IN INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE, THE NOMINATION COMMITTEE AND THE REMUNERATION AND APPRAISAL COMMITTEEDownload -
-
-
-
-
-
-
-
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR, PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CLOSURE OF REGISTER OF MEMBERS OF H SHARESDownload -
-
INSIDE INFORMATION ANNOUNCEMENT - PROPOSED PARTICIPATION IN THE H SHARE FULL CIRCULATION PROGRAMME BY THE COMPANYDownload -
-
VOLUNTARY ANNOUNCEMENT FURTHER INFORMATION ABOUT THE STRATEGIC COLLABORATION WITH QUANTOBIODownload -
-
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021Download -
(1) 2020 REPORT OF THE BOARD OF DIRECTORS (2) 2020 REPORT OF THE BOARD OF SUPERVISORS (3) 2020 ANNUAL REPORT AND ITS ABSTRACT (4) 2020 FINANCIAL ACCOUNTS REPORT (5) 2021 FINANCIAL BUDGET (6) 2020 PROFIT DISTRIBUTION PLAN (7) RE-APPOINTMENT OF AUDITORS (8)Download -
-
Form of Proxy for use at the 2020 Annual General Meeting to be held on Tuesday, June 8, 2021Download -
-
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021Download -
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020 AND CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONGDownload -
-
-
-
-
-
-
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021Download -
PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIODDownload -
-
-
-
-
-
-
-
